H. Shapiro

发表

Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema.

P. Campochiaro, C. Wykoff, H. Shapiro, 2014, Ophthalmology.

Effects of Pd-bacteriopheophorbide (TOOKAD)-Mediated Photodynamic Therapy on Canine Prostate Pretreated with Ionizing Radiation

B. Wilson, F. Hetzel, Qun Chen, 2004, Radiation research.

Hyperoxygenation Enhances the Tumor Cell Killing of Photofrin‐mediated Photodynamic Therapy ¶

F. Hetzel, Qun Chen, H. Shapiro, 2003 .

Hyperoxygenation Enhances the Tumor Cell Killing of Photofrin-mediated Photodynamic Therapy¶

F. Hetzel, Qun Chen, H. Shapiro, 2003, Photochemistry and photobiology.

Improvement of Tumor Response by Manipulation of Tumor Oxygenation During Photodynamic Therapy ¶

F. Hetzel, Qun Chen, H. Shapiro, 2002 .

Clinical observations of axillary involvement for tubular, lobular, and ductal carcinomas of the breast

H. Shapiro, C. Leonard, P. Philpott, 1999, Journal of surgical oncology.

Subgroup Analysis of First–Year Results of ANCHOR: A Phase III, Double–Masked, Randomized Comparison of Ranibizumab and Verteporfin Photodynamic Therapy for Predominantly Classic Choroidal Neovascularization Related to Age–Related Macular Degeneration

H. Shapiro, David M. Brown, S. Schneider, 2006 .

Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials.

P. Rosenfeld, B. Blodi, H. Shapiro, 2011, Ophthalmology.

Impact of Cataract Surgery during Treatment with Ranibizumab in Patients with Diabetic Macular Edema.

A. Moshfeghi, H. Shapiro, Shamika Gune, 2015, Ophthalmology. Retina.

Patterns of Early and Delayed Visual Response to Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration.

R. Dreyer, H. Shapiro, G. Kokame, 2016, JAMA ophthalmology.

Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials.

A. Ho, K. Freund, H. Shapiro, 2010, American journal of ophthalmology.

Lumpectomy and Breast Radiotherapy in Breast Cancer Patients with a Family History of Breast Cancer, Ovarian Cancer, or Both

H. Shapiro, C. Leonard, J. Ponce, 2002, The breast journal.

FixedMonthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-RelatedMacular Degeneration

L. Morse, H. Shapiro, L. Tuomi, 2014 .

Ranibizumab treatment outcomes in phakic versus pseudophakic eyes: an individual patient data analysis of 2 phase 3 trials.

H. Shapiro, J. Ehrlich, D. Weinberg, 2013, Ophthalmology.

Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trials.

P. Rosenfeld, H. Shapiro, J. Ehrlich, 2011, American journal of ophthalmology.

Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography.

P. Campochiaro, R. Bhisitkul, H. Shapiro, 2013, Ophthalmology.

Regional infusion of urokinase into occluded lower-extremity bypass grafts: long-term clinical results.

D. C. Brewster, T. Walker, W. Abbott, 1989, Radiology.

Laser-assisted penetration of topical anesthetic in adults.

F. Hetzel, H. Shapiro, D. Bar-Or, 2003, Archives of dermatology.

Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration.

R. Bhisitkul, C. Awh, H. Shapiro, 2007, Ophthalmology.

Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results.

P. Kaiser, F. Holz, H. Shapiro, 2007, American journal of ophthalmology.

ANATOMICAL MEASURES AS PREDICTORS OF VISUAL OUTCOMES IN RANIBIZUMAB-TREATED EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

H. Shapiro, David M. Brown, L. Tuomi, 2013, Retina.

The upper gastrointestinal tract in patients ungergoing chronic dialysis.

H. Shapiro, S. N. Wiener, V. Vertes, 1969, Radiology.

Excision Only for Tubular Carcinoma of the Breast

H. Shapiro, C. Leonard, J. Ponce, 2005, The breast journal.

Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion.

P. Campochiaro, R. Bhisitkul, H. Shapiro, 2013, Ophthalmology.

Low albumin level in the emergency department: a potential independent predictor of delayed mortality in blunt trauma.

H. Shapiro, D. Bar-Or, R. Yukl, 2003, The Journal of emergency medicine.

Predicting vision gains with anti-VEGF therapy in neovascular age-related macular degeneration patients by using low-luminance vision

H. Shapiro, R. Frenkel, I. Stoilov, 2015, British Journal of Ophthalmology.

Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.

Peter K Kaiser, Barbara A Blodi, P. Kaiser, 2007, Ophthalmology.

Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer.

D. Thickman, H. Shapiro, P. Philpott, 1996, The Journal of urology.

Amifostine Used as a Normal Tissue Protectant in Patients Receiving Pelvic Radiotherapy

H. Shapiro, C. Leonard, K. Dahl, 2005 .

Improvement of Tumor Response by Manipulation of Tumor Oxygenation During Photodynamic Therapy¶

Zheng Huang, Jill Beckers, F. Hetzel, 2002, Photochemistry and photobiology.

Ranibizumab for Neovascular Age-Related Macular Degeneration (AMD): Optical Coherence Tomography (OCT) vs. Visual Acuity (VA) Changes in PIER Study

H. Shapiro, David M. Brown, M. Benz, 2008 .

ANATOMICAL BENEFIT FROM RANIBIZUMAB TREATMENT OF PREDOMINANTLY CLASSIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN THE 2-YEAR ANCHOR STUDY

S. Sadda, T. Ianchulev, B. Blodi, 2010, Retina.

THE EFFECT OF FELLOW EYE VISUAL ACUITY ON VISUAL ACUITY OF STUDY EYES RECEIVING RANIBIZUMAB FOR AGE-RELATED MACULAR DEGENERATION

H. Shapiro, Namrata Saroj, S. Zweifel, 2012, Retina.

Randomized, Controlled Phase III Study of Ranibizumab (LucentisTM) for Minimally Classic or Occult Neovascular Age–Related Macular Degeneration: Two–Year Efficacy Results of the MARINA Study

Joan W. Miller, H. Shapiro, N. Acharya, 2006 .

MARINA STUDY GROUP. SUBGROUP ANALYSIS OF THE MARINA STUDY OF RANIBIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

R. Bhisitkul, C. Awh, H. Shapiro, 2007 .

Laser assisted delivery of topical anesthesia for intramuscular needle insertion in adults

F. Hetzel, H. Shapiro, D. Bar-Or, 2002, Lasers in surgery and medicine.

Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular Degeneration

L. Morse, H. Shapiro, P. Wong, 2012, Journal of ophthalmology.

The Denver II: a major revision and restandardization of the Denver Developmental Screening Test.

Philip Archer, H. Shapiro, W. Frankenburg, 1992, Pediatrics.

Patterns of Early and Delayed Visual Response to Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration.

R. Dreyer, H. Shapiro, G. Kokame, 2016, JAMA ophthalmology.

Ranibizumab treatment outcomes in phakic versus pseudophakic eyes: an individual patient data analysis of 2 phase 3 trials.

H. Shapiro, J. Ehrlich, D. Weinberg, 2013, Ophthalmology.